Search Results 521-530 of 91070 for Metastasis
A Study to Evaluate the Safety of Lasofoxifene in Combination with Abemaciclib in Advanced or Metastatic ER+/HER2− Breast Cancer with ESR1 Mutation. Print ...
... metastatic colorectal or pancreatic cancer whose disease is stable on, or responding to 1st line therapy for metastatic disease. Participation eligibility.
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer. Print details. Share; Facebook ...
His team uses techniques spanning biochemistry, molecular and cell biology, and animal modeling to better understand the mechanisms that regulate metastasis.
A Phase 1/2a Study of IMM-1-104 in Participants With Previously Treated, RAS-Mutant, Advanced or Metastatic Solid Tumors · More about research at Mayo Clinic.
... metastases. Stage 4 (metastatic) colon cancer. Symptoms & causes · Diagnosis & treatment · Doctors & departments · Care at. Mayo Clinic. Research: It's all ...
Tucatinib and Trastuzumab for Patients with HER2-positive Metastatic Colorectal Cancer ... Exceptions are malignancies with a negligible risk of metastasis or ...
Sinonasal malignant melanoma with diffuse metastasis: F-18 FDG PET/CT imaging. Online publication at http://radiology.casereports.net/index.php/rcr. 2008; 3(1).
Understanding Facilitators and Barriers that Impact Capacity and Workload for Caregivers of Metastatic Cancer Patients · Overview · Participation eligibility.
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.